Sign In
Buy IMCR
$29.20
-0.150 (-0.511%)
At Close: Jun 23, 2026
New Strong Buy Stocks for January 7th
08:21am, Tuesday, 07'th Jan 2025
AORT, VERX, NN, IMCR and EVER have been added to the Zacks Rank #1 (Strong Buy) List on January 7, 2024.
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference
07:00am, Monday, 06'th Jan 2025
Immunocore to present at the 43rd Annual J.P. Morgan Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn.
Immunocore appoints Travis Coy, previously a Non-Executive Director, as its EVP, Chief Financial Officer and Head of Corporate Development
3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025
02:10pm, Thursday, 26'th Dec 2024
Here we present three biotech stocks, ALLO, DAWN and IMCR, which took a beating in 2024 but have upside potential for 2025.
Buy 5 Genomics & Synthetic Biology Stocks Likely to Soar in Short Term
08:50am, Monday, 23'rd Dec 2024
These five geonomics and synthetic biology stocks are likely to soar in the short-term. They Are: CRSP, IMCR, GLUE, RIGL, CSTL.
Immunocore announces first patient dosed in the Phase 1 trial of IMC-P115C, a half-life extended (HLE) ImmTAC candidate in patients with tumors that express PRAME
Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?
02:10pm, Friday, 13'th Dec 2024
Morgan Stanley downgraded Amicus Therapeutics Inc FOLD. Over the last year, the company has executed well commercially, met its goals financially by achieving nonGAAP profitability for 2024, and settl
All You Need to Know About Immunocore (IMCR) Rating Upgrade to Strong Buy
01:06pm, Thursday, 12'th Dec 2024
Immunocore (IMCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for December 12th
07:21am, Thursday, 12'th Dec 2024
NBBK, OMCL, ZIM, IMCR and ULS have been added to the Zacks Rank #1 (Strong Buy) List on December 12, 2024.
Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
Does Immunocore (IMCR) Have the Potential to Rally 112.82% as Wall Street Analysts Expect?
11:01am, Thursday, 28'th Nov 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 112.8% in Immunocore (IMCR). While the effectiveness of this highly sought-after metric is questionable, the po
New Strong Buy Stocks for November 26th
07:26am, Tuesday, 26'th Nov 2024
ZIM, MNDY, RSI, IMCR and ULS have been added to the Zacks Rank #1 (Strong Buy) List on November 26, 2024.
3 Fast-Growing Stocks Analysts See Doubling in Price
07:16am, Monday, 11'th Nov 2024
Comparing and selecting stocks for investment may involve any number of increasingly complex strategies and approaches, but sometimes simpler is better: targeting a stock with significant upside poten
Wall Street Analysts Predict an 112.56% Upside in Immunocore (IMCR): Here's What You Should Know
10:55am, Friday, 08'th Nov 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 112.6% in Immunocore (IMCR). While the effectiveness of this highly sought-after metric is questionable, the po
Immunocore to present at upcoming investor conferences
07:00am, Friday, 08'th Nov 2024
(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 8 November 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology c
